The Impact of Inflammatory Markers and Obesity in Chronic Venous Disease

被引:1
|
作者
Petrascu, Flavia-Medana [1 ,2 ]
Matei, Sergiu-Ciprian [3 ,4 ]
Margan, Madalin-Marius [5 ,6 ]
Ungureanu, Ana-Maria [7 ]
Olteanu, Gheorghe-Emilian [1 ,8 ,9 ]
Murariu, Marius-Sorin [3 ,4 ]
Olariu, Sorin [3 ,4 ]
Marian, Catalin [1 ,2 ,10 ]
机构
[1] Victor Babes Univ Med, Dept Doctoral Studies & Pharm, Timisoara 300041, Romania
[2] Victor Babes Univ Med & Pharm, Dept Biochem, Timisoara 300041, Romania
[3] Victor Babes Univ Med & Pharm, Abdominal Surg & Phlebol Res Ctr, Timisoara 300041, Romania
[4] Pius Brinzeu Emergency Cty Hosp, Surg Dept 1, Timisoara 300723, Romania
[5] Victor Babes Univ Med & Pharm, Dept Funct Sci, Discipline Publ Hlth, Timisoara 300041, Romania
[6] Victor Babes Univ Med & Pharm, Fac Med, Ctr Translat Res & Syst Med, Timisoara 300041, Romania
[7] Victor Babes Univ Med & Pharm, Dept Radiol & Med Imaging, Timisoara 300041, Romania
[8] Victor Babes Univ Med & Pharm, Fac Pharm, Res Ctr Pharmaco Toxicol Evaluat, Timisoara 300041, Romania
[9] Victor Babes Univ Med & Pharm, Ctr Res & Innovat Personalized Med Resp Dis, Timisoara 300041, Romania
[10] Victor Babes Univ Med & Pharm, Ctr Complex Networks Sci, Timisoara 300041, Romania
关键词
obesity; inflammation; chronic venous disease; endothelial dysfunction; microcirculatory damage; C-REACTIVE PROTEIN; INSUFFICIENCY; MANAGEMENT; COMPRESSION; DISORDERS;
D O I
10.3390/biomedicines12112524
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Chronic venous disease (CVD) represents a significant health challenge, particularly in obese individuals. This study focuses on the interplay between inflammation, obesity, and CVD, by analyzing the role of inflammatory markers in the disease progression. Methods: Clinical and paraclinical data of 619 patients hospitalized and treated in the Phlebology Department (1stSurgical Department, "Pius Br & icirc;nzeu" Emergency County Hospital Timisoara, Romania) between 2018 and 2024 were analyzed. Results: The statistical analysis revealed that age, C-reactive protein (CRP), fibrinogen, and absolute neutrophil count (ANC) were key predictors of CVD progression. Specifically, elevated CRP and fibrinogen levels correlated strongly with increased CVD severity, particularly in patients with higher body-mass index (BMI). BMI, while not an independent predictor, contributed indirectly to the disease severity through its association with these inflammatory markers. The logistic regression model incorporating age, BMI, CRP, fibrinogen, and ANC demonstrated a high predictive accuracy, with an area under the curve (AUC) of 0.902, highlighting the models reliability in stratifying patients at risk for severe CVD. Conclusions: This predictive model not only aids in identifying high-risk patients but also reinforces inflammation as a critical therapeutic target in CVD management.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Negative impact of deep venous thrombosis on chronic venous disease
    Lozano Sanchez, Francisco S.
    Ramon Gonzalez-Porras, Jose
    Diaz Sanchez, Santiago
    Marinel.lo Roura, Josep
    Sanchez Nevarez, Ignacio
    Carrasco Carrasco, Eduardo
    Escudero Rodriguez, Jose Roman
    THROMBOSIS RESEARCH, 2013, 131 (04) : E123 - E126
  • [2] Popliteal vein compression, obesity, and chronic venous disease
    Millen, Rebecca N.
    Thomas, Kate N.
    Versteeg, Matthew P. T.
    van Rij, Andre M.
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2022, 10 (01) : 200 - +
  • [3] Factors impeding venous return and their impact on the management of chronic venous disease
    Raiker, Ashna
    Labropoulos, Nicos
    PHLEBOLYMPHOLOGY, 2022, 29 (03) : 83 - 88
  • [4] Pathophysiology of Chronic Venous Disease and Venous Ulcers
    Raffetto, Joseph D.
    SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (02) : 337 - +
  • [5] A scoping review on Chronic Venous Disease and the development of a Venous Leg Ulcer: The role of obesity and mobility
    Meulendijks, A. M.
    Franssen, W. M. A.
    Schoonhoven, L.
    Neumann, H. A. M.
    JOURNAL OF TISSUE VIABILITY, 2020, 29 (03) : 190 - 196
  • [6] Magnesium, inflammation, and obesity in chronic disease
    Nielsen, Forrest H.
    NUTRITION REVIEWS, 2010, 68 (06) : 333 - 340
  • [7] The metabolic syndrome, smoking, inflammatory markers and obesity
    Kawada, Tomoyuki
    Otsuka, Toshiaki
    Endo, Tokiomi
    Kon, Yoichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 151 (03) : 367 - 368
  • [8] The influence of compression therapy on the levels of inflammatory biomarkers in patients with chronic venous disease
    Tkaczyk, Jedrzej
    Przywara, Stanislaw
    Ilzecka, Joanna
    Ilzecki, Marek
    ACTA ANGIOLOGICA, 2021, 27 (01): : 32 - 36
  • [9] MicroRNA expression biomarkers of chronic venous disease
    Zalewski, Daniel
    Chmiel, Paulina
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2022, 35 (01) : 21 - 26
  • [10] Impact of OSA on Biological Markers in Morbid Obesity and Metabolic Syndrome
    Salord, Neus
    Gasa, Merce
    Mayos, Mercedes
    Maria Fortuna-Gutierrez, Ana
    Maria Montserrat, Josep
    Sanchez-de-la-Torre, Manuel
    Barcelo, Antonia
    Barbe, Ferran
    Vilarrasa, Nuria
    Monasterio, Carmen
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2014, 10 (03): : 263 - U31